PEAK6 Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
PEAK6 Group's PFE Position: Q2 2018 in Review
PEAK6 Group sold out of Pfizer (PFE) in Q2 2018, closing a stake of 412,038 shares — an estimated $14.1M sold.
PEAK6 Group first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $13.9M in Q1 2018. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.
- PEAK6 Group reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
- PEAK6 Group sold 412,038 Pfizer shares in Q2 2018, an estimated $14.1M.
- PEAK6 Group first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
- PEAK6 Group's Pfizer position peaked at $13.9M in Q1 2018.
- 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.
Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.